Welcome to our dedicated page for Abacus Global Management news (Ticker: ABLLW), a resource for investors and traders seeking the latest updates and insights on Abacus Global Management stock.
Abacus Life Inc (ABLLW) provides investors with comprehensive updates on its alternative asset management strategies and life insurance market activities. This dedicated news hub aggregates all official announcements, financial disclosures, and strategic developments from the vertically integrated investment manager.
Access real-time updates on earnings reports, policy portfolio acquisitions, and regulatory compliance matters. The curated collection serves as a reliable resource for tracking the company's management of life settlement investments throughout their lifecycle. Content spans operational milestones, risk management initiatives, and industry-specific developments relevant to alternative asset investors.
Key updates include strategic partnerships, portfolio performance insights, and innovations in data-driven investment approaches. Users can expect factual reporting on ABLLW's unique position at the intersection of insurance markets and alternative asset management. All information is verified through primary sources to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to ABLLW's latest developments. Regularly updated content supports informed decision-making for stakeholders monitoring the specialized life insurance investment sector.
Abacus Life (NASDAQ: ABL) reported Q3 2024 results with total revenue growing 33% year-over-year to $28.1 million. Despite posting a GAAP net loss of $5.1 million due to a non-cash warrant liability increase, the company achieved significant growth metrics with Adjusted Net Income up 65% to $14.9 million and Adjusted EBITDA rising 54% to $16.7 million. Policy originations increased 54% to 278, with capital deployment of $93.2 million. The company is advancing its ABL Tech platform with over 20 clients and progressing on acquisitions of Carlisle Management and FCF Advisors, expected to add $2.6 billion in assets under management.
Abacus Life (NASDAQ: ABL) has released preliminary Q3 2024 results, anticipating Total Revenue between $26.0 and $28.0 million, representing a 23-33% year-over-year growth. The company expects a GAAP Net Loss between $6.0 and $6.75 million, primarily due to a non-cash increase in warrant liability of $8.0 to $9.0 million. Adjusted EBITDA is projected between $14.0 and $16.0 million, showing a 30-48% year-over-year growth.
CEO Jay Jackson highlighted key acquisitions of Carlisle Management Company SCA and FCF Advisors, as well as the addition of new executives. The company also partnered with Lorisco to launch PREADISAN™, a health prediction and actuarial technology tool. Abacus will release full Q3 2024 financial results on November 7, 2024, followed by a conference call.
Abacus Life (NASDAQ: ABL), a leader in longevity and actuarial technology asset management, has appointed Robert F. Phillips as Senior Vice President, Investor Relations and Corporate Affairs. With over 30 years of experience in capital markets and investor relations, Phillips will lead Abacus Life's investor relations strategy and play a key role in advancing strategic business initiatives. Reporting directly to CEO Jay Jackson, Phillips will focus on strengthening engagement with investment and capital markets communities.
Phillips' extensive background includes roles as Senior Managing Director at Nasdaq, heading Investor Relations and Business Development for an SEC-registered investment advisor, and experience in institutional trading & brokerage. He holds a B.A. from Hamilton College and an M.B.A. in Finance from NYU Stern School of Business.
Abacus Life, Inc. (NASDAQ: ABL), a leading global alternative asset manager specializing in lifespan-based financial products, has announced a significant milestone for its Abacus Policy Value Calculator. The calculator, which recently launched its newest generation, has surpassed 150,000 individual submissions from insureds, representing more than $87 billion in face value.
CEO Jay Jackson emphasized the company's commitment to providing instant access to their valuation database through the calculator. This tool offers insureds a transparent and up-to-date estimate of their policy's value. The high volume of submissions has allowed Abacus to further refine its models and actuarial databases, enhancing the accuracy of its valuations.
Abacus Life (NASDAQ: ABL), a leading global alternative asset manager specializing in lifespan-based financial products, has announced the appointment of Corey McLaren as Managing Director, Capital Markets. Based in Boston, McLaren brings nearly two decades of financial services experience, including over 15 years in life settlements.
McLaren's previous roles include Director of Alternative Strategies at Spearhead Capital, where he managed their life settlement investment fund, and Director at FDO Partners, where he helped launch and source policies for three life settlement funds. Abacus CEO Jay Jackson expressed excitement about McLaren's expertise and its potential to drive the company's strategic vision forward.
Abacus Life (NASDAQ: ABL) and Lorisco Life have announced the launch of PREADISAN™, a cutting-edge health prediction platform that combines machine learning and modern proteomics. This partnership aims to revolutionize longevity-based health prediction and actuarial technology in the life settlements industry.
PREADISAN™ introduces a novel risk score that utilizes blood-based proteomic biomarker analysis and clinically driven AI models to assess mortality risks. This tool goes beyond traditional statistics-based life expectancy opinions, offering individualized insights for more personalized financial planning.
The partnership enables Abacus to enhance its leading capabilities in life settlements and actuarial technology, providing customized financial offerings based on Lorisco's health prediction platform. This collaboration is expected to significantly impact the future of financial planning and life settlements by focusing on longevity and health predictions.
Abacus Life (NASDAQ: ABL) reported strong Q2 2024 results, with total revenue doubling year-over-year to $29.1 million. The company's adjusted net income grew 75% to $11.8 million, while adjusted EBITDA increased 83% to $16.7 million. Abacus completed a public equity offering raising over $90 million, which was deployed towards new policy originations and growth initiatives. The company also announced two significant acquisitions: Carlisle Management and FCF Advisors, expected to add approximately $2.6 billion in assets under management. These moves align with Abacus' strategy to expand its global presence and diversify its product offerings in the longevity and actuarial technology space.
Abacus Life (NASDAQ: ABL) has announced a definitive agreement to acquire FCF Advisors, a New York-based asset manager specializing in free cash flow-focused investment strategies. This acquisition aligns with Abacus' expansion of ABL Wealth and will add up to $600 million in assets under management to the company. FCF Advisors is known for its free cash flow analytics and research, offering over 50 customizable free cash flow index strategies across 8 global equities allocation categories.
The deal is expected to close in the fourth quarter of 2024, subject to customary closing conditions. This strategic move aims to enhance Abacus Life's ability to provide comprehensive, lifespan-based financial advisory services and products, furthering its goal of delivering holistic and tailored financial solutions to clients throughout their lives.
Abacus Life (NASDAQ: ABL) has released preliminary Q2 2024 results, showing strong growth. The company expects:
- Total Revenue between $28.0-$30.0 million (146-163% YoY growth)
- Net Income between $0.0-$1.0 million
- Adjusted EBITDA between $15.0-$17.0 million (64-86% YoY growth)
CEO Jay Jackson highlighted key achievements, including a successful public offering raising over $90 million and a new distribution partnership with AIMCOR. Abacus also announced an agreement to acquire Carlisle Management Company SCA. The company will release full Q2 2024 results on August 12, 2024.
Abacus Life (NASDAQ: ABL) has announced a definitive agreement to acquire Carlisle Management Company SCA, a Luxembourg-based investment manager in the life settlement space, for approximately $200 million. This strategic acquisition will add up to $2 billion in assets under management to Abacus, accelerating its expansion as a global alternative asset manager. The deal aligns with Abacus' goal of enhancing its offering to institutional investors seeking attractive risk-adjusted returns with low correlation to other asset classes.
Key points of the acquisition include:
- Carlisle shareholders will receive $73.5 million in Abacus bonds and 9.3 million Abacus common stock
- The transaction is subject to regulatory approval and certain performance thresholds
- Carlisle is licensed as an Alternative Investment Fund Manager under CSSF oversight in Luxembourg
- The acquisition is expected to provide synergies and expand Abacus' global financial presence
FAQ
What is the current stock price of Abacus Global Management (ABLLW)?
